Engineering antibodies for speed & success
Bridging the gap between biological promise and clinical success through early screening of key developability targets.
Get StartedBacked By
Redefining how antibodies are designed, de-risked, and delivered
Smarter lead selection begins here. Bridging the gap between AI and biology.
Actimo builds computational systems that understand binding at a foundational level and translate it into key antibody developability insights. Our platform enables partners to eliminate downstream failure, accelerate programs, and maximise the value of every molecule.
How We Accelerate Your Pipeline
From initial screening to IND submission, Actimo supports every critical stage of antibody development.
Applicable for various antibody teams.
Accelerate hit-to-lead progression and explore greater sequence diversity — faster. Actimo helps you identify, characterise, and prioritise candidates with confidence.
Purpose-built for teams developing therapeutics, diagnostics, biosimilars, and more.
Talk to a SpecialistReagent Manufacturing
Streamline antibody development for high-quality reagent production with rapid characterization.
Diagnostics
Accelerate diagnostic antibody discovery with precise binding and specificity analysis.
Biosimilar Discovery
Compare and optimize biosimilar candidates with comprehensive functional profiling.
Novel Therapeutic Discovery
Fast-track therapeutic antibody development from hit identification to lead optimization.
Vaccine Development
Identify and characterize protective antibodies for next-generation vaccine design.
Cell and Gene Therapy
Engineer precision antibodies for targeted cell therapy and gene delivery applications.
Private by design. Your data remains isolated, access-controlled, and exclusively yours.
Plus, we operate with full transparency & you retain full ownership of your IP.
Cost Efficient
Get up to 3 epitope mapping analyses for free. Dramatically reduce costs compared to traditional methods.
High Resolution & Throughput
Overcome common challenges seen in traditional methods such as NGS and SPR with verified, high-resolution results.
Accelerated Timeline
Get results in minutes instead of months, dramatically speeding up your therapeutic development cycle.
Privacy Protection
Your antibody and protein data is never shared. Strict access controls with complete data segregation.
Sequence Only Inputs
No structural data required—just provide your antibody sequences and let our platform handle the rest.
Secure Infrastructure
Built on industry-leading cloud infrastructure with audit logs, backups, and compliance standards.
Frequently Asked Questions
Find answers to common questions about our platform and technology